Your browser doesn't support javascript.
loading
Human endeavor for anti-SARS-CoV-2 pharmacotherapy: A major strategy to fight the pandemic.
Wang, Ruixuan; Stephen, Preyesh; Tao, Yi; Zhang, Wenfa; Lin, Sheng-Xiang.
Affiliation
  • Wang R; Axe Molecular Endocrinology and Nephrology, CHU Research Center and Laval University, Quebec City, Quebec, G1V 4G2, Canada.
  • Stephen P; Axe Molecular Endocrinology and Nephrology, CHU Research Center and Laval University, Quebec City, Quebec, G1V 4G2, Canada.
  • Tao Y; Axe Molecular Endocrinology and Nephrology, CHU Research Center and Laval University, Quebec City, Quebec, G1V 4G2, Canada.
  • Zhang W; Axe Molecular Endocrinology and Nephrology, CHU Research Center and Laval University, Quebec City, Quebec, G1V 4G2, Canada.
  • Lin SX; Axe Molecular Endocrinology and Nephrology, CHU Research Center and Laval University, Quebec City, Quebec, G1V 4G2, Canada. Electronic address: sxlin@crchul.ulaval.ca.
Biomed Pharmacother ; 137: 111232, 2021 May.
Article in En | MEDLINE | ID: mdl-33486202

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Type of study: Prognostic_studies Limits: Humans Language: En Journal: Biomed Pharmacother Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Type of study: Prognostic_studies Limits: Humans Language: En Journal: Biomed Pharmacother Year: 2021 Document type: Article Affiliation country: Country of publication: